Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Pulmonary Rehabilitation Care Group, The Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group.
- Who it may be relevant to
- Registry conditions: Respiratory Diseases, Cardiovascular Diseases, Cerebrovascular Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, to evaluate the therapeutic effect of Pulmonary rehabilitation exercise and usual care for three months. And finally, to build a trinity model of rehabilitation management of COPD patients. The objective of this project is to establish and promote the application of diagnostic and treatment norms.
Detailed description
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person)，CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention. And finally, to build a trinity model of rehabilitation management of COPD patients.
Interventions
- Combination product Pulmonary Rehabilitation Care Group
participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbatio - Other The Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group
participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person)，CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilati
Primary outcome measures
- The proportion of high-risk and diagnosed individuals with COPD [Time frame: through study completion, an average of 4 year]
- the improvement of acute exacerbation frequency (times/year/person) [Time frame: through study completion, an average of 4 year]
Secondary outcome measures (3)
- Blood pressure [Time frame: through study completion, an average of 4 year]
- blood lipids [Time frame: through study completion, an average of 4 year]
- FBG(fasting blood-glucose) [Time frame: through study completion, an average of 4 year]
Eligibility criteria
Inclusion criteria
- Committed to adhering to the study protocol and cooperating with the implementation of the entire research process.
- Aged 18 years or older, regardless of gender.
- Signed informed consent form.
Exclusion criteria
- Individuals with severe mental illness.
- Individuals assessed by medical personnel as having a disease that requires immediate hospitalization or a severe, uncontrollable condition that is life-threatening in the short term.
- Women who are pregnant, breastfeeding, or using inappropriate contraception methods.
- Individuals who refuse to cooperate with follow-up questionnaires or specimen collection.
- Patients currently participating in other interventional clinical drug trials.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Other
Study locations
China · 1 center
- Union hospital, Tongji Medical college, Huazhong University of Science and Technology — Wuhan
Identifiers
NCT: NCT07090200 · XHJY-Chronic disease · 2023ZD0509905